Elekta AB (publ) (EKTA-B) - Total Assets
Based on the latest financial reports, Elekta AB (publ) (EKTA-B) holds total assets worth Skr27.68 Billion SEK (≈ $2.98 Billion USD) as of January 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check EKTA-B cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Elekta AB (publ) - Total Assets Trend (2002–2025)
This chart illustrates how Elekta AB (publ)'s total assets have evolved over time, based on quarterly financial data. Explore Elekta AB (publ) (EKTA-B) investment intensity to see how much of total assets are deployed in long-term investments.
Elekta AB (publ) - Asset Composition Analysis
Current Asset Composition (April 2025)
Elekta AB (publ)'s total assets of Skr27.68 Billion consist of 46.3% current assets and 53.7% non-current assets.
| Asset Category | Amount (SEK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr2.45 Billion | 10.2% |
| Accounts Receivable | Skr7.71 Billion | 26.6% |
| Inventory | Skr2.76 Billion | 9.5% |
| Property, Plant & Equipment | Skr1.91 Billion | 6.6% |
| Intangible Assets | Skr11.92 Billion | 41.1% |
| Goodwill | Skr6.89 Billion | 23.8% |
Asset Composition Trend (2002–2025)
This chart illustrates how Elekta AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see market cap of Elekta AB (publ).
Key Asset Composition Facts
- Current vs. Non-Current Assets: Elekta AB (publ)'s current assets represent 46.3% of total assets in 2025, a decrease from 80.4% in 2002.
- Cash Position: Cash and equivalents constituted 10.2% of total assets in 2025, down from 21.1% in 2002.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 64.0% of total assets, an increase from 15.0% in 2002.
- Asset Diversification: The largest asset category is intangible assets at 41.1% of total assets.
Elekta AB (publ) Competitors by Total Assets
Key competitors of Elekta AB (publ) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
COCHLEAR LTD ADR 1/2/O.N.
F:OC50
|
Germany | €2.83 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.89 Billion |
|
Novocure Ltd
NASDAQ:NVCR
|
USA | $787.93 Million |
|
Shanghai MicroPort EV MedTech Co. Ltd. A
SHG:688351
|
China | CN¥2.00 Billion |
|
Jafron Biomedical Co Ltd
SHE:300529
|
China | CN¥5.52 Billion |
|
Anteris Technologies Global Corp
AU:AVR
|
Australia | AU$19.07 Million |
|
Beijing Chunlizhengda Medical Instruments Co Ltd
SHG:688236
|
China | CN¥3.54 Billion |
|
Tellgen Corp
SHE:300642
|
China | CN¥2.01 Billion |
Elekta AB (publ) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.95 | 1.06 | 1.11 |
| Quick Ratio | 0.73 | 0.83 | 0.92 |
| Cash Ratio | 0.18 | 0.25 | 0.00 |
| Working Capital | Skr-723.00 Million | Skr887.00 Million | Skr1.31 Billion |
Elekta AB (publ) - Advanced Valuation Insights
This section examines the relationship between Elekta AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.68 |
| Latest Market Cap to Assets Ratio | 0.07 |
| Asset Growth Rate (YoY) | -7.8% |
| Total Assets | Skr28.98 Billion |
| Market Capitalization | $2.04 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Elekta AB (publ)'s assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Elekta AB (publ)'s assets decreased by 7.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Elekta AB (publ) (2002–2025)
The table below shows the annual total assets of Elekta AB (publ) from 2002 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-04-30 | Skr28.98 Billion ≈ $3.12 Billion |
-7.75% |
| 2024-04-30 | Skr31.41 Billion ≈ $3.38 Billion |
+6.10% |
| 2023-04-30 | Skr29.61 Billion ≈ $3.19 Billion |
+12.57% |
| 2022-04-30 | Skr26.30 Billion ≈ $2.83 Billion |
+5.87% |
| 2021-04-30 | Skr24.84 Billion ≈ $2.67 Billion |
-12.55% |
| 2020-04-30 | Skr28.41 Billion ≈ $3.06 Billion |
+18.06% |
| 2019-04-30 | Skr24.06 Billion ≈ $2.59 Billion |
+7.16% |
| 2018-04-30 | Skr22.46 Billion ≈ $2.42 Billion |
+7.19% |
| 2017-04-30 | Skr20.95 Billion ≈ $2.25 Billion |
+7.76% |
| 2016-04-30 | Skr19.44 Billion ≈ $2.09 Billion |
-8.23% |
| 2015-04-30 | Skr21.18 Billion ≈ $2.28 Billion |
+18.40% |
| 2014-04-30 | Skr17.89 Billion ≈ $1.93 Billion |
+9.72% |
| 2013-04-30 | Skr16.31 Billion ≈ $1.75 Billion |
+7.04% |
| 2012-04-30 | Skr15.23 Billion ≈ $1.64 Billion |
+70.00% |
| 2011-04-30 | Skr8.96 Billion ≈ $964.45 Million |
+5.25% |
| 2010-04-30 | Skr8.52 Billion ≈ $916.35 Million |
+7.09% |
| 2009-04-30 | Skr7.95 Billion ≈ $855.65 Million |
+25.77% |
| 2008-04-30 | Skr6.32 Billion ≈ $680.35 Million |
+18.04% |
| 2007-04-30 | Skr5.36 Billion ≈ $576.39 Million |
+1.36% |
| 2006-04-30 | Skr5.28 Billion ≈ $568.64 Million |
+17.45% |
| 2005-04-30 | Skr4.50 Billion ≈ $484.16 Million |
+46.26% |
| 2004-04-30 | Skr3.08 Billion ≈ $331.03 Million |
+3.85% |
| 2003-04-30 | Skr2.96 Billion ≈ $318.76 Million |
+16.80% |
| 2002-04-30 | Skr2.54 Billion ≈ $272.91 Million |
-- |
About Elekta AB (publ)
Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers linear accelerator and radiation therapy products comprising Elekta Unity for anatomy-specific MR imaging; Elekta Evo that delivers offline and online adaptive radiation therapy; Elekta Versa … Read more